Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

538 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Minimal influence of tocilizumab on IFN-gamma synthesis by tuberculosis antigens.
Ogata A, Mori M, Hashimoto S, Yano Y, Fujikawa T, Kawai M, Kuwahara Y, Hirano T, Arimitsu J, Hagihara K, Shima Y, Narazaki M, Yokota S, Kishimoto T, Kawase I, Tanaka T. Ogata A, et al. Mod Rheumatol. 2010 Apr;20(2):130-3. doi: 10.1007/s10165-009-0243-4. Epub 2009 Nov 7. Mod Rheumatol. 2010. PMID: 19898919
The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.
Shima Y, Kuwahara Y, Murota H, Kitaba S, Kawai M, Hirano T, Arimitsu J, Narazaki M, Hagihara K, Ogata A, Katayama I, Kawase I, Kishimoto T, Tanaka T. Shima Y, et al. Among authors: ogata a. Rheumatology (Oxford). 2010 Dec;49(12):2408-12. doi: 10.1093/rheumatology/keq275. Epub 2010 Sep 5. Rheumatology (Oxford). 2010. PMID: 20819796 Free PMC article.
Tocilizumab for the treatment of rheumatoid arthritis.
Tanaka T, Ogata A, Narazaki M. Tanaka T, et al. Among authors: ogata a. Expert Rev Clin Immunol. 2010 Nov;6(6):843-54. doi: 10.1586/eci.10.70. Expert Rev Clin Immunol. 2010. PMID: 20979549 Review.
538 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page